Cancer-associated thrombosis risk assessment
“Machine learning (ML) is a novel technique used for the diagnosis and prognosis of several diseases, including cancer-associated thrombosis, when trained on specific diagnostic modalities. Consolidating the literature on the use of ML for the prediction of cancer-associated thrombosis is necessary to understand its diagnostic and prognostic abilities relative to KS” El-Sherbini et al (2024).
PICC-related venous thrombosis in patients with lymphoma – Full Text
“The objective of this study is to examine the risk factors associated with the occurrence of PICC-Related Venous Thrombosis (PICC-RVTE) in individuals diagnosed with lymphoma, as well as to develop a predictive risk nomogram model” Wang et al (2024).
VTE prophylaxis in cancer patients with CVC – Full Text
“The introduction of direct oral anticoagulants (DOACs), with its proven efficacy and safety in multiple clinical indications, have renewed the attention to VTE prophylaxis in cancer patients with CVC” Abdel-Razeq and Al-Jaghbeer (2024).
Central venous catheter-related thrombosis guidelines – Full Text
“The overall quality of the guidelines is high, but there are few preventive measures for central venous CRT involved in the guidelines. All preventive measures have yet to be systematically integrated and evaluated, and no risk assessment scale dedicated to this field has been recommended” Zhang et al (2024).
PICC-related UEDVT prediction model
“The risk of PICC-related UEDVT can be estimated and predicted relatively accurately by using the method of ML modeling, so as to effectively reduce the incidence of PICC-related UEDVT in the future” Hu et al (2024).
Embolisms caused by central venous catheter thrombus – Full Text
“Here, we report a case of simultaneous coronary and lower limb artery embolism in a PFO patient carrier of a CVC. The patient presented to the hospital with acute chest pain and lower limb fatigue. Doppler ultrasound showed a large thrombus in the right internal jugular vein, precisely at the tip of the CVC” Li et al (2024).
Venous thromboembolism management in people with cystic fibrosis
“Nine PwCF with a total of 12 unique VTE episodes were included in the study, with all but one episode associated with a peripherally inserted central catheter (PICC)” Abbinanti et al (2023).
CVC-related UEDVT in sickle cell disease – Full Text
“Individuals with sickle cell disease (SCD) and central venous catheters (CVC) are at high risk for venous thromboembolism (VTE)” Abdulrehman et al (2024).
PICC associated UEDVT case report – Full Text
“A 22-year-old male with a history of Crohn’s disease developed swelling and purplish discoloration at the brachial site of a PICC line site” Singh et al (2023).
PICC-related venous thrombosis in patients with cancer – Full Text
“The purpose of this study was to understand and analyze the risk factors of peripherally inserted central catheter (PICC)-related venous thrombosis in adult patients with cancer” Wang et al (2024).
Interventions for UEDVT in cancer patients – Full Text
“Therapeutic anticoagulation was not associated with a reduction in the incidence of recurrent VTE or increase the incidence of bleeding in adult cancer patients following a CVC-associated DVT diagnosis” Ngo et al (2024).
Upper extremity venous thrombosis study
“To assess the prevalence of UEVT in hospitalized patients and study thrombosis risk factors according to their location” Espitia et al (2023).
Preventive effect of aspirin on PICC-related vein thrombosis
“The incidence of PICC-related VT was 0.4% in the aspirin group, compared with 3.3% in the control group (P = 0.038). In addition, aspirin related bleeding was not observed” Yu et al (2023).
Management of UEDVT in cancer patients
“In symptomatic patients, venous ultrasound is the most appropriate choice for first-line diagnostic imaging of CRT because it is noninvasive, and its diagnostic performance is high (which is not the case in asymptomatic patients)” Elias et al (2023).
Management of catheter-related upper extremity deep vein thrombosis
“Our study demonstrated a relatively low rate of recurrent VTE and moderate rate of major bleeding events within the first 3 months in patients with cancer and catheter-related upper extremity DVT” Wang and Kou (2023).
Central catheter-associated thrombosis study
“The results showed that the focus population of CVC-RT research has changed from pediatric patients to cancer patients, the management of CVC-RT has become more formal and standardized, and the focused CVC type has shifted to port and peripherally inserted central catheters” Liu et al (2023).
UEDVT prophylactic strategy
“Our objective was to evaluate the safety and efficacy of an anti-FXI mAb, gruticibart (AB023), in a prospective, single-arm study of patients with cancer receiving central line placement” Pfeffer et al (2023).
Upper extremity deep vein thrombosis risk factors – Full Text
“In the background of UEDVT, the combination of indwelling CV catheter placement and malignancy was frequently observed. While the risk of recurrence or PE complications is low, the prognosis of UEDVT complicated by malignancy is extremely poor” Endo et al (2023).
PICC-related thrombosis in cancer patients
“PICC-related thrombosis is common and can occur very early post insertion in cancer patients, and most thromboses present atypical symptoms” Zhang et al (2023).
UEDVT risk factors for implantable ports – Full Text
“This study aims to investigate the incidence of and risk factors for TIVADs-related thrombotic occlusion in patients with breast cancer” Liu et al (2023).
PICC diameter and UEDVT rate – Full Text
“We assessed the relationship between peripherally inserted central catheter (PICC) diameters and symptomatic deep vein thrombosis (DVT) rates” Bahl et al (2023).
Central venous catheter thrombosis case study – Full Text
“We describe two cases of CVC-related thrombosis (Hickman-catheter) complicated by recurrent pulmonary emboli. One patient experienced a complete thromboembolic obstruction of the right pulmonary artery with normal pulmonary pressures and the second patient suffered from a central thromboembolic obstruction of both pulmonary arteries associated with severe pulmonary hypertension” Hanuna et al (2023).
Risks factors for catheter-related deep venous thrombosis
“We observed a high incidence of both CR-DVT and PE/LE-DVT with overlapping and unique risk factors. CR-DVT was also associated with increased mortality similar to PE/LE-DVT” Averyet al (2023).
PICC associated right heart thrombus – Full Text
“We present two cases of right heart thrombus in transit with pulmonary thromboembolism resulting from venous thrombosis associated with peripherally inserted central catheters that were managed with different approaches” Hussain et al (2023).
Impact of vein diameter on PICC-related UEDVT
“Inserting catheters in veins with bigger vascular diameter and faster blood flow velocity may help reduce the incidence of PICCRT. The first week post catheter insertion is the key intervention period for the prevention of PICCRT” Xu et al (2023).
PICC-related venous thrombosis in cancer patients
“A total of 19 articles involving 19,824 patients were included for quantitative analysis. Meta-analysis of these studies indicated that a history of chemotherapy, tumor type, tumor stage, presence or absence of metastasis, and use of fluorouracil, etoposide, platinum drugs, and taxane were all risk factors for PICC catheter thrombosis in cancer patients” Ma et al (2023).
Risk prediction model for PICC-related venous thrombosis – Full Text
“The independent risk factors for PICC-related venous thrombosis are screened out, including catheter tip position, plasma D-dimer elevation, venous compression, history of thrombosis and history of PICC/CVC catheterization, and a nomogram prediction model with good effect is constructed to predict the risk of PICC-related venous thrombosis” Chen et al (2023).
Central venous catheter related pulmonary embolism in an infant – Full Text
“We reported an infant who suffered from huge lumen-like pulmonary embolism with possible origin from thrombi around the prolonged indwelling central venous catheter” Wu et al (2023).
Cancer-associated thrombosis management – Full Text
“In this article, we review the prior and recent landmark studies that have directed the treatment of cancer-associated thrombosis, and discuss specific factors that affect management as well as future treatment considerations” Ramcharitar et al (2023).
Thromboembolism risk factors in children with CVC
“The findings of this study provide new insights on risk factor differences between CRT and non-CRT. Prevention efforts should be directed at modifying the type of CVC, insertion location and/or number of CVCs placed if possible, to decrease the incidence of CRT” Jaffray et al (2023).